LigaSure™ technology has been used in more than 25 million procedures worldwide.1
"7 Reasons Why" you want to bring the Right Energy to your thoracic cases with the LigaSure™ Maryland jaw thoracic device (LF1930T):
We're working hard to transform lung health - from identifying patients earlier to optimizing treatment to accelerating recovery. It's why we're committed to offering a comprehensive suite of technologies tailored for thoracic surgery.
† Based on a US database search of Ethicon Enseal, Harmonic, Olympus Thunderbeat, Medtronic, Applied Medical, Aesculap devices (March 10, 2019).
§ Based on systemic vasculature.
Φ Tissue sticking to device jaws instances measured over 110 seals per device (ForceTriad™ energy platform). F1930T is only compatible with the Valleylab™ FT10 energy platform.
Ω Cleaning effectiveness assessed after each of two cleaning cycles.
1. Based on internal sales data from FY01‑FY20. October 2019.
2. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™ LF1930T device (memo). March 29, 2018.
3. LigaSure™ Maryland Jaw Thoracic Sealer/Divider, Nano‑Coated [instructions for use]. Boulder, CO: Medtronic; 2017. ±As of Nov. 19, 2018, based on indications for use for laparoscopic LigaSure™ devices.
4. Based on internal report #RE00138840, LIG‑45 memo, device length recommendation, thoracic (LF1930T). Feb. 6, 2018.
5. Based on internal test report #RE00125866, Jaw force and gap range burst pressure evaluation of EB4 thoracic Maryland device (LF1930T); conducted on bovine tissue. Nov. 20 –21, 2017 and Nov. 27–30, 2017.
6. Based on internal test report #RE00134865, Burst pressure verification of pulmonary bovine veins using the LigaSure™ LF1930T device. Jan. 17–18, 2018.
7. Based on internal test report #RE00122515, Verification of the LigaSure™ LF1930T device in a GLP chronic hemostasis canine study on pulmonary vasculature. Jan. 8–10, 2018.
8. Based on internal test report #RE00128442, GLP acute pulmonary vasculature hemostasis verification study of the LigaSure™ LF1930T device in hounds. Dec. 8, 2017
9. Based on internal test report #RE00140529 rev A, LigaSure™ Maryland device, nano‑coated (LF19X X) tissue testing (memo). March 5, 2018
10. Based on internal test report #RE00071598, Maryland validation labs, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30 –May 3, 2013. ≠ 30 of 33 surgeons surveyed after use.
11. Based on internal test report #R0035742, Maryland validation, Houston and Los Angeles: independent surgeon feedback collected during porcine labs. April 16–18 and April 30–May 3, 2013.
12. Based on internal test report #R0032385 rev A, Thermal profile comparison of Ethicon Harmonic™* HD1000i shears versus nano‑coated LigaSure™ Maryland jaw device on the Valleylab™ FT10 energy platform. May 17–18, 2017 and June 14, 2017.
13. LigaSure™ Maryland Jaw Sealer/Divider, Nano‑Coated [instructions for use]. Boulder, CO: Medtronic; 2016.
14. Okada M, Miyata Y, Takamochi K, Tsutani Y, Oh S, Suzuki K. Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery. J Thorac Cardiovasc Sur. 2018.
15. Based on internal test report #RE00073194, Tissue sticking comparison of the Ethicon G2™*, Voyant™* 5 mm Fusion, LigaSure™ LF1737, and LigaSure™ LF1937 devices conducted on porcine tissue using the ForceTriad™ energy platform. Jan. 18, 2017.
16. Based on internal report #RE00147462, Pulmonary sealing claims for the LigaSure™LF1930T device (memo). March 29, 2018.
17. Based on internal test report #RE00071599, LF19XX MJC marketing claims testing conducted on porcine tissue, Feb. 7–22, 2017.